Results 281 to 290 of about 448,959 (307)

Interleukin-13 receptor α2: glioma's unlucky receptor?

Cytotherapy, 2012
openaire   +2 more sources

Cancer gene therapy utilizing interleukin-13 receptor alpha2 chain.

Current gene therapy, 2005
Cancer cells are known to express cell surface molecules such as specific antigens or cytokine receptors, e.g., EGFR, Fas/CD95, gp100, HER-2/neu, IL-13Ralpha2, and MAGE. Among them, interleukin-13 receptor (IL-13R) alpha2 chain is expressed on certain types of cancer cells including glioblastoma, AIDS Kaposi's sarcoma, and head and neck cancer.
openaire   +1 more source

[Interleukin-13 and interleukin-13 receptor in Hodgkin's disease].

Polskie Archiwum Medycyny Wewnetrznej, 2003
Zofia Monika, Rupniewska, Małgorzata, Wach   +1 more
openaire   +1 more source

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Andrea Rubbert-Roth, César R Ramos-Remus, Rieke E Alten   +2 more
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello, Anna Simon, Jos W M Van Der Meer   +2 more
exaly  

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Lancet, The, 2013
Antoinette Moran, Linda A Dimeglio, Stephen E Gitelman   +2 more
exaly  

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
B G Feagan, Julian Panes, Arthur Kaser
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, John Gregson, Peter Willeit   +2 more
exaly  

Article on Interleukin 13 Receptor α2 Chain

Clinical Cancer Research, 2006
openaire   +1 more source